HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target

被引：0
作者：
Madhuwanti Srinivasan
Souresh Banerjee
Allison Palmer
Guoxing Zheng
Aoshuang Chen
Maarten C. Bosland
André Kajdacsy-Balla
Ramaswamy Kalyanasundaram
Gnanasekar Munirathinam
机构：
[1] University of Illinois,Department of Biomedical Sciences
[2] College of Medicine,Department of Pathology
[3] University of Illinois at Chicago,undefined
[4] University of Illinois Cancer Center,undefined
来源：
Hormones and Cancer | 2014年 / 5卷
关键词：
Ethyl Pyruvate; Clear Cell Renal Cell Carcinoma; Glycyrrhetinic Acid; Cervical Squamous Cell Carcinoma; HMGB1 Level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
High-mobility group box 1 (HMGB1) is a dynamic nuclear protein participating in transcription, chromatin remodelling, and DNA recombination and repair processes. Accumulating evidence indicates that its function now extends beyond the nucleus, notably its extracellular role in inflammation. HMGB1 is implicated as a late mediator of sepsis and is also believed to promote atherosclerosis and other inflammatory diseases such as rheumatoid arthritis and systemic lupus erythematosus. Interestingly, deregulation of HMGB1 is shown to be associated with the hallmarks of cancer development. Moreover, several clinical studies have shown that HMGB1 is a promising biomarker for a variety of cancer types. In this review, we provide novel insights into the role and mechanisms of HMGB1, in particular, to hormone-related cancers and its potential to serve as a therapeutic target.
引用
收藏
页码：127 / 139
页数：12
相关论文
共 746 条
[41]  
Davalos AR(2005)Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development Prostate 64 92-538
[42]  
Kawahara M(2013)HMGB1: a promising therapeutic target for prostate cancer Prostate Cancer 2013 157103-295
[43]  
Malhotra GK(2009)Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels Croat Med J 50 455-751
[44]  
Schaum N(2012)High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy J Transl Med 10 135-238
[45]  
Huang J(2010)High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness Am J Respir Cell Mol Biol 43 530-1183
[46]  
Ved U(2008)Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma Zhonghua Zhong Liu Za Zhi 30 292-1027
[47]  
Beausejour CM(2013)High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy Eur J Cancer 49 741-61
[48]  
Coppe JP(2012)HMGB1 promotes drug resistance in osteosarcoma Cancer Res 72 230-276
[49]  
Rodier F(2010)The redox protein HMGB1 regulates cell death and survival in cancer treatment Autophagy 6 1181-5068
[50]  
Campisi J(2012)The expression of high mobility group box 1 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma Pathol Oncol Res 18 1021-1868
12345678910